Key facts
- This page summarizes Jacob Safier's Form 4 filing for Orgenesis Inc. (ORGS).
- 9 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 04 Dec 2024, 18:48.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Sale
Purchase
Sale
Purchase
Sale
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Award
Additional SEC filing notes
Section 16 status
Jacob Safier is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
On September 25, 2024, the Issuer effected a reverse stock split at a ratio of 1-for-10. The share amounts set forth here are presented before giving effect to the reverse stock split.
Footnote F2
The Reporting Person is the portfolio manager of the investment in the Issuer by JSAF Holdings, LLC ("JSAF") and may therefore be deemed to beneficially own the shares owned by JSAF. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Footnote F3
Pursuant to an Amended and Restated Promissory Note, dated as of August 10, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 1") exercisable for 970,873 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
Footnote F4
Other than 53,970 shares currently exercsiable, Warrant 1 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act"), more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.
Footnote F5
Pursuant to an Amended and Restated Promissory Note, dated as of September 9, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 2") exercisable for 242,718 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
Footnote F6
Warrant 2 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.
Footnote F7
Pursuant to an Amended and Restated Promissory Note, dated as of November 4, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 3") exercisable for 242,718 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
Footnote F8
Warrant 3 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.